Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing the Effects of Empagliflozin and Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity

NCT06140108 is registered in ClinicalTrials.gov with SINA Health Education and Welfare Trust as lead sponsor.

NCT NCT06140108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06140108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing the Effects of Empagliflozin and Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity
Lead sponsor
SINA Health Education and Welfare Trust
Phase
Phase 2/3
Overall status
Completed
Start date
December 15, 2023
Completion date
June 30, 2024
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hba1c, polycystic ovary syndrome, weight gain